Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Y Katherine Xu is an analyst at William Blair. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/20/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/18/2025 | INCY | Buy Now | Incyte | $60.34 | — | Y Katherine Xu75% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 01/24/2019 | INCY | Buy Now | Incyte | $60.34 | 65.73% | Y Katherine Xu75% | $85 → $100 | Upgrade | Market Perform → Outperform | Get Alert |
| 04/06/2018 | INCY | Buy Now | Incyte | $60.34 | — | Y Katherine Xu75% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 09/18/2017 | ARWR | Buy Now | Arrowhead Pharma | $15.47 | — | Y Katherine Xu75% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 01/25/2017 | ALBO | Buy Now | Albireo Pharma | — | — | Y Katherine Xu75% | — | Initiates | → Outperform | Get Alert |
| 11/30/2016 | ARWR | Buy Now | Arrowhead Pharma | $15.47 | — | Y Katherine Xu75% | — | Downgrade | Outperform → Market Perform | Get Alert |
